|
FHI
FHI’s programs and research have helped foster many breakthroughs: FHI-led clinical trials have evaluated nearly every type of modern contraceptive method, leading to approval and introduction in many countries. FHI was the first to demonstrate that antiretroviral therapy can be delivered on a large scale in low-income countries, through practices we established and promoted. FHI helped establish the effectiveness of nevirapine in preventing mother-to-child transmission of HIV. FHI led work that is advancing the development of new HIV prevention technologies, microbicides and pre-exposure prophylaxis. We worked on the development of a vaccine for rotovirus, a diarrhea-causing virus that leads to the deaths of more than half a million children each year FHI has a team of professionals with extensive expertise in evidence-based OVC programming and has worked for more than a decade to improve the wellbeing of OVC in Africa and around the world, reaching more than 800,000 children to date with evidence based solutions, services and support. FHI has ample experience designing and implementing complex, multi-country programs in Africa. One example is the Faith-based Regional Initiative for Children (FABRIC), a five year program implemented in Zambia, Namibia and South Africa that reached more than 17,500 OVC with comprehensive services. FHI has also developed strategies and guidance to ensure high quality programming for OVC at the country level, such as the Child Outreach Strategy, which is FHI’s Strategic Framework for HIV/AIDS Programs Focusing on OVC, and the Quality Improvement Guidelines for Care and Support Programs for Orphans and Other Vulnerable Children. Using these tools, FHI has worked to strengthen the organizational, financial and technical capacity of its local implementing partners to help them become key stakeholders in their country’s national response to OVC. For more information about FHI, please visit our website at www.fhi.org.
|
|

















